GlassScriptPhysician profile
Marcus L Stephens
NPI 1063808061
$1,880.61
in general payments reported to CMS, 2019-2025
13 companies · $414 in 2025
The $414 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $854 · 2024: $613 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $519.91 | 2023-2025 | General - Pain Management |
| Globus Medical, INC. | $298.26 | 2024-2025 | Xlif, Nvm5, Creo |
| Medtronic, INC. | $232.05 | 2023-2024 | Mazor X System, Intellis Adaptivestim, Midas Rex |
| Aesculap, INC. | $171.43 | 2023-2025 | Aesculap, M.Blue |
| Abbott Laboratories | $152.35 | 2024 | Proclaim |
| Depuy Synthes Sales INC. | $124.56 | 2024-2025 | Matrixneuro, Trumatch |
| Bioventus LLC | $121.90 | 2023-2024 | Bonescalpel, Nexus-10 Mkii |
| Gt Medical Technologies, INC | $114.20 | 2024 | Gammatile |
| Integra Lifesciences Corporation | $62.82 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Csl Behring | $34.98 | 2023 | Kcentra |
| Lilly USA, LLC | $19.23 | 2023 | Emgality |
| Chiesi USA, INC. | $17.16 | 2025 | Cleviprex |
| Spineology INC. | $11.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.